Defining trajectories of response in patients with psoriasis treated with biologic therapies

Overview of attention for article published in British Journal of Dermatology, June 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter: 5 X users

Readers on

mendeley: 26 Mendeley

So far, Altmetric has seen 8 X posts from 5 X users, with an upper bound of 18,133 followers.

https://t.co/sdyO3Alf0k https://t.co/FAoN1W7FVU https://t.co/1aoYzBCh8A https://t.co/GdA0Sovoze https://t.co/es8dKzYr7X https://t.co/aAcHHGBQoL https://t.co/TWQ3drHVsa https://t.co/iEcpsF9h57 https://t.co/bOy0G6orPo

RT @profbuchan: Latent classes of biologic treatment response in psoriasis in the near term, indicating many more journeys of inflammation…

Latent classes of biologic treatment response in psoriasis in the near term, indicating many more journeys of inflammation to understand (upstream and downstream of the focal therapy, and across co-morbidities): https://t.co/70RuHPcalo @NopharGeifman

Using a data-driven approach, the authors identified four subgroups of patients with #psoriasis defined by #global trajectories of response to #biologic therapies. #dermtwitter https://t.co/VdX4lngrQz

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 4 additional X posts.